Search

Your search keyword '"Infectieziekten onderzoek1 (Bont)"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Infectieziekten onderzoek1 (Bont)" Remove constraint Author: "Infectieziekten onderzoek1 (Bont)"
226 results on '"Infectieziekten onderzoek1 (Bont)"'

Search Results

101. Contact With Young Children Increases the Risk of Respiratory Infection in Older Adults in Europe-the RESCEU Study

102. World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults

103. A systematic review on global RSV genetic data: Identification of knowledge gaps

104. Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study

105. RSV: perspectives to strengthen the need for protection in all infants

106. Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol (BMC Infectious Diseases, (2021), 21, 1, (857), 10.1186/s12879-021-06544-3)

110. COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works

111. Publisher Correction:: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

112. Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions

113. Are changes in practice a cause of the rising burden of bronchiolitis for paediatric intensive care units?

114. The Association between Weather Conditions and Admissions to the Paediatric Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis

115. Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol

116. Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSV

117. Neutrophils in respiratory syncytial virus infection: From harmful effects to therapeutic opportunities

118. Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

120. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

122. Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at 6 years of age

123. Global Respiratory Syncytial Virus-Related Infant Community Deaths

124. Burden of respiratory syncytial virus bronchiolitis on the Dutch pediatric intensive care units

125. Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): An international prospective cohort study

126. Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step

127. TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines

129. Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study

130. Defining asthma in children: how well do parents, doctors and spirometry agree?

131. Effectiviteit van influenzavaccinatie bij kinderen: Tijd voor een ander beleid?

132. Comparison of illumina versus nanopore 16s rRNA gene sequencing of the human nasal microbiota

133. Transcriptome of airway neutrophils reveals an interferon response in life-threatening respiratory syncytial virus infection

134. Complement genes contribute sex-biased vulnerability in diverse disorders

135. Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV

136. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis

137. Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

138. Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial

139. Life-threatening bronchiolitis in children: eight decades of critical care

140. Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants

141. Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe

142. Respiratory Syncytial Virus-related Death in Children with down Syndrome: The RSV GOLD Study

143. Low Sensitivity of BinaxNOW RSV in Infants

144. Global molecular diversity of RSV - the 'INFORM RSV' study

145. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting

146. Signal inhibitory receptor on leukocytes (SIRL)-1 and leukocyte- associated immunoglobulin-like receptor (LAIR)-1 regulate neutrophil function in infants

147. Measles seroprevalence in pregnant women in Soweto, South Africa: a nested cohort study

148. Correction to: Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants (vol 177, pg 133, 2018)

Catalog

Books, media, physical & digital resources